Recall Ledger

Olanzapine Tablets recall (Macleods Pharmaceuticals Limited)

DrugClass IIIOngoing

Summary: Macleods Pharmaceuticals Limited is recalling Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.. Reason: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

What is being recalled

Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.

Why

Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

How serious is it

Class III is the least serious level: using or being exposed to this product is not likely to cause health problems, but it breaks FDA rules.

Where it was sold

Nationwide in the USA

How to tell if yours is affected

Lot: BOB22321A, Exp 07-31-2027.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0867-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass III
StatusOngoing
Recall startedAugust 27, 2026
ReportedSeptember 30, 2026
CompanyMacleods Pharmaceuticals Limited
Company locationTehsil Baddi, District Solan, India
Initiated byVoluntary: Firm initiated
Quantity22,032 30-count bottles

More recalls from Macleods Pharmaceuticals Limited · all drug recalls · recalls from August 2026

Official FDA record